Search

everythinglearnresearchcommunity

for

Search:↓

Botulinum Toxin A may help with hair growth and has some side effects; more research is needed.

The UK Intellectual Property Office allows granting of supplementary protection certificates with negative terms.

Recent legal rulings favored Genentech, Teva, and upheld guidelines for patent term extensions.

Excessive body hair can signal complex health issues.

Old neuropharmacological drugs might be effective for treating inflammatory skin diseases.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

The cause and importance of misplaced oil glands in the hair follicle are not well understood.

A six-year-old boy with excessive hair growth and other symptoms may have a genetic link on chromosome 17q, requiring regular medical follow-ups.

The document concludes that pediatricians play a vital role in supporting adolescents through puberty and should enhance their competence in this area.

The medical student learned to balance medical knowledge with empathy when delivering difficult news to patients.

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

Men with urinary symptoms are more likely to have erectile dysfunction, and there's a debate about research methods and authorship ethics.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

Dosage regime inventions can be patentable in China, but legal uncertainty exists.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

The UK Court of Appeal ruled that new dosing regimens for drugs can be patented, aligning with the European Patent Office's approach.

Australian court ruled that Bickfords did not infringe on Monster Energy's trade mark because Monster was not sold or known in Australia at the time.

The document updates on EU legal changes, including pharmaceutical patents, class actions in Italy, and various drug-related rulings.

Europe strengthened medicine regulations, increased protection against counterfeit drugs, and made it tougher to challenge comparative advertising, while also focusing on patent law enforcement and updating plant protection rules.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

The document concludes that the exact way alcohol causes harm to fetal development is unknown, but it significantly affects nutrient transport to the fetus and a safe level of alcohol during pregnancy is not determined.

Alternative medicine lacks scientific support and relies on the placebo effect, but remains popular and integrated into German healthcare.

Using longer PEG chains helps nanoparticles penetrate hair follicles better, improving drug delivery for conditions like alopecia.

A woman with acromegaloidism and normal growth hormone levels had a rare X-Tetrasomy, suggesting a need to study X-chromosome genes for their role in growth and facial development.

The document concludes that ideal facial proportions are guided by specific measurements and symmetry to enhance beauty, but individual characteristics must be considered.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

Glycyrrhizic acid and licorice extract can significantly reduce unwanted hair growth.

Patents don't guarantee money; inventors must work hard and stay involved.

The UK High Court revoked Lundbeck's patent for Escitalopram, and second medical use claims based on dosage were not considered novel.